Schroder Investment Management Group’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,500,183
| Closed | -$22.7M | – | 1345 |
|
|
2022
Q3 | $22.7M | Sell |
1,500,183
-594,628
| -28% | -$9M | 0.04% | 412 |
|
|
2022
Q2 | $15.7M | Sell |
2,094,811
-257,183
| -11% | -$1.93M | 0.02% | 533 |
|
|
2022
Q1 | $21.4M | Buy |
2,351,994
+999,040
| +74% | +$9.09M | 0.03% | 481 |
|
|
2021
Q4 | $9.5M | Buy |
1,352,954
+19,990
| +1% | +$140K | 0.01% | 619 |
|
|
2021
Q3 | $15.2M | Sell |
1,332,964
-66,381
| -5% | -$757K | 0.02% | 537 |
|
|
2021
Q2 | $22.4M | Sell |
1,399,345
-12,109
| -0.9% | -$194K | 0.03% | 490 |
|
|
2021
Q1 | $25.2M | Buy |
1,411,454
+8,479
| +0.6% | +$152K | 0.03% | 447 |
|
|
2020
Q4 | $19M | Buy |
1,402,975
+257,300
| +22% | +$3.48M | 0.03% | 496 |
|
|
2020
Q3 | $13.7M | Buy |
1,145,675
+29,637
| +3% | +$355K | 0.02% | 516 |
|
|
2020
Q2 | $16.5M | Buy |
1,116,038
+13,435
| +1% | +$198K | 0.03% | 449 |
|
|
2020
Q1 | $13.2M | Buy |
1,102,603
+267
| +0% | +$3.2K | 0.03% | 473 |
|
|
2019
Q4 | $26.6M | Buy |
+1,102,336
| New | +$26.6M | 0.04% | 428 |
|
|
2016
Q1 | – | Sell |
-471,000
| Closed | -$11.5M | – | 1244 |
|
|
2015
Q4 | $11.5M | Buy |
471,000
+51,500
| +12% | +$1.25M | 0.02% | 597 |
|
|
2015
Q3 | $7.44M | Sell |
419,500
-765,800
| -65% | -$13.6M | 0.02% | 659 |
|
|
2015
Q2 | $20.4M | Buy |
1,185,300
+709,600
| +149% | +$12.2M | 0.04% | 463 |
|
|
2015
Q1 | $14.7M | Buy |
475,700
+95,500
| +25% | +$2.95M | 0.03% | 558 |
|
|
2014
Q4 | $11.1M | Sell |
380,200
-23,900
| -6% | -$698K | 0.02% | 619 |
|
|
2014
Q3 | $8.36M | Hold |
404,100
| – | – | 0.01% | 703 |
|
|
2014
Q2 | $10M | Buy |
404,100
+2,400
| +0.6% | +$59.4K | 0.01% | 636 |
|
|
2014
Q1 | $8.51M | Sell |
401,700
-15,900
| -4% | -$337K | 0.01% | 667 |
|
|
2013
Q4 | $7.5M | Buy |
+417,600
| New | +$7.5M | 0.01% | 719 |
|